The short version
- Why people research itFocus, memory, neuroprotection, mood and stress resilience.
- What the evidence isReached phase 2 as a potential adjunct treatment for schizophrenia.
- What to watchA seizure, or muscle jerks that you cannot suppress.
How Neboglamine works
Positive allosteric modulator of the glycine site on the NMDA receptor — it enhances NMDA signaling without directly agonizing it, which theoretically avoids excitotoxicity.
Neboglamine is not a peptide, a racetam or a piperazine. It is an amino acid derivative: (4S)-4-amino-5-[(4,4-dimethylcyclohexyl)amino]-5-oxopentanoic acid, C13H24N2O3, molecular weight 256.34 National Center for Biotechnology Information 2026.
The target is the glycine co-agonist site of the NMDA receptor, and the pharmacology is unusually precisely defined. Lanza 1997 measured NMDA-evoked release of [3H]noradrenaline from rat hippocampal slices and asked a sharp question: does this compound change glycine's potency or its efficacy? The answer was efficacy only.
- Oral
On the goal map: Glutamatergic & synaptic plasticity (Focus, memory & cognition)
Research on Neboglamine4 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Evidence on file: Trialed as a schizophrenia adjunct then discontinued; no efficacy data published.
Human clinical evidence
Reached phase 2 as a potential adjunct treatment for schizophrenia. Development did not continue, and detailed results were not widely published — an outcome that leaves the compound in an unusually undefined state for something that reached that stage.
Correlative data
Essentially no community use, and no published series. The absence is worth stating: unlike most compounds here there is no anecdotal layer, so there is very little to weigh in either direction.
How the mechanism reads
A positive allosteric modulator of the glycine site on the NMDA receptor — it makes the receptor more responsive to glycine rather than activating it directly.
MechanisticNMDA hypofunction is a long-standing hypothesis in schizophrenia, and allosteric modulation is the safer way to address it: it enhances existing signaling rather than forcing it, which limits excitotoxic risk.
Mechanistic
Sources
- Lanza M, Bonnafous C, Colombo S. Characterization of a novel putative cognition enhancer mediating facilitation of glycine effect on strychnine-resistant sites coupled to NMDA receptor complex.. Neuropharmacology 1997 · PMID 9294970
- Garofalo P, Colombo S, Lanza M. CR 2249: a new putative memory enhancer. Behavioural studies on learning and memory in rats and mice.. J Pharm Pharmacol 1996 · PMID 9004193
- Chiusaroli R, Garofalo P, Espinoza S. Antipsychotic-like effects of the N-methyl-D-aspartate receptor modulator neboglamine: an immunohistochemical and behavioural study in the rat.. Pharmacol Res 2010 · PMID 20045056
- National Center for Biotechnology Information. PubChem Compound Summary for CID 3074827, Neboglamine.. PubChem, retrieved 2026
Neboglamine safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Seizure history or past stroke: boosting NMDA signaling raises neuronal excitability.
- Ketamine, memantine or dextromethorphan use: they block the receptor this compound sensitizes.
- Wanting an approved product: development stopped, so identity and purity rest on the seller.
- Pregnancy: glycine-site NMDA modulation has no data in fetal brain development.
What’s expected
- Often nothing clearly felt, since it only amplifies signals glutamate already sends.
- Light restlessness or a sharper, more wired mood in some users.
- Headache or vivid dreams.
Watch for
- A seizure, or muscle jerks that you cannot suppress.
- New paranoia, agitation or disorientation.
- Severe or thunderclap headache.
- Several nights of near-total insomnia.
Labs that tell you it’s working
- Magnesium
- Magnesium, RBC
- Comprehensive Metabolic Panel (CMP)
- Cortisol
Neboglamine is a positive allosteric modulator at the NMDA glycine site, gated by magnesium; the trials stopped without published efficacy. PMID 20045056
Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Neboglamine FAQ4 common questions
- Is Neboglamine approved for human use?
- No. Neboglamine is a research compound.
- What is Neboglamine researched for?
- Focus, memory, neuroprotection, mood and stress resilience.
- Which labs show whether it's doing anything?
- Magnesium; Magnesium, RBC; Comprehensive Metabolic Panel; Cortisol: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Neboglamine: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.



